MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

04 Aug 2026 Evaluate
The sales for the June 2026 quarter moved down to Rs. 2931.13 millions as compared to Rs. 3547.58 millions during the year-ago period.The Company's Net profit for the June 2026 quarter have declined marginally to Rs. 782.64  millions as against Rs. 911.70 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 1133.12 millions from 1292.48 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2931.13 3547.58 -17.38 2931.13 3547.58 -17.38 9473.21 10299.85 -8.03
Other Income 152.37 82.54 84.60 152.37 82.54 84.60 686.54 462.56 48.42
PBIDT 1133.12 1292.48 -12.33 1133.12 1292.48 -12.33 3627.53 4239.86 -14.44
Interest 6.60 6.90 -4.35 6.60 6.90 -4.35 62.39 0.98 6266.33
PBDT 1126.52 1285.58 -12.37 1126.52 1285.58 -12.37 3565.14 4238.88 -15.89
Depreciation 67.06 56.98 17.69 67.06 56.98 17.69 240.02 177.89 34.93
PBT 1059.46 1228.60 -13.77 1059.46 1228.60 -13.77 3325.12 4060.99 -18.12
TAX 276.82 316.90 -12.65 276.82 316.90 -12.65 846.96 1008.96 -16.06
Deferred Tax 11.82 18.90 -37.46 11.82 18.90 -37.46 34.06 41.21 -17.35
PAT 782.64 911.70 -14.16 782.64 911.70 -14.16 2478.16 3052.03 -18.80
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 38.66 36.43 6.11 38.66 36.43 6.11 38.29 41.16 -6.98

Blue Jet Healthcare Share Price

587.45 -7.50 (-1.26%)
14-Aug-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: